Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Reilly

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Neurology|March 9, 2005
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cordM Laura, W Leong, N M F Murray, et al.
Neurology|April 22, 2011
MFN2 mutations cause severe phenotypes in most patients with CMT2AS M E Feely, M Laura, C E Siskind, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2008
The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective studyD L H Bennett, M Groves, J Blake, et al.
Neuromuscular Disorders : NMD|April 3, 2012
Hand weakness in Charcot-Marie-Tooth disease 1XP J Arthur-Farraj, S M Murphy, M Laura, et al.
Muscle & Nerve|June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndromeA Petzold, J Brettschneider, K Jin, et al.
Neuromuscular Disorders : NMD|August 4, 2018
Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathyA Silwal, M Pitt, R Phadke, et al.
Brain : a Journal of Neurology|August 1, 1995
Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathyM M Reilly, D Adams, D R Booth, et al.
Brain : a Journal of Neurology|March 10, 1999
Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosisM Brett, M R Persey, M M Reilly, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2006
Primary sciatic nerve lymphoma: a case report and review of the literatureM J L Descamps, L Barrett, M Groves, et al.
Human Molecular Genetics|August 15, 2019
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1XA Kagiava, J Richter, C Tryfonos, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Neurology|March 9, 2005
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cordM Laura, W Leong, N M F Murray, et al.
Neurology|April 22, 2011
MFN2 mutations cause severe phenotypes in most patients with CMT2AS M E Feely, M Laura, C E Siskind, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2008
The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective studyD L H Bennett, M Groves, J Blake, et al.
Neuromuscular Disorders : NMD|April 3, 2012
Hand weakness in Charcot-Marie-Tooth disease 1XP J Arthur-Farraj, S M Murphy, M Laura, et al.
Muscle & Nerve|June 18, 2009
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndromeA Petzold, J Brettschneider, K Jin, et al.
Neuromuscular Disorders : NMD|August 4, 2018
Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathyA Silwal, M Pitt, R Phadke, et al.
Brain : a Journal of Neurology|August 1, 1995
Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathyM M Reilly, D Adams, D R Booth, et al.
Brain : a Journal of Neurology|March 10, 1999
Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosisM Brett, M R Persey, M M Reilly, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2006
Primary sciatic nerve lymphoma: a case report and review of the literatureM J L Descamps, L Barrett, M Groves, et al.
Human Molecular Genetics|August 15, 2019
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1XA Kagiava, J Richter, C Tryfonos, et al.
Pageof 7